An Effectiveness Evaluation for Pathway to Healthy Aging (Path-HA) Care on Health Status of Older Adults
1 other identifier
interventional
1,000
1 country
1
Brief Summary
The goal of this clinical trial is to provide a scientific evaluation on the effects of a protocol-driven Pathway to Healthy Aging (Path-HA) Program on promoting the health-related quality of life and functional abilities of older adults who are at risk of accelerated aging in the community. Participants will be randomized to one of the two study arms: 1) the intervention group to receive a 14-week Path-HA care intervention; and 2) the control group with no Path-HA care intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2023
CompletedFirst Posted
Study publicly available on registry
October 30, 2023
CompletedStudy Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedDecember 16, 2025
December 1, 2025
1.5 years
October 23, 2023
December 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Health-related quality of life
Measured by the EQ-5D-5L questionnaire (scores range from -0.59 to 1.0), with a higher score indicating better quality of life.
Changes from baseline to 3-month and 9-month post-intervention
Secondary Outcomes (11)
Hand grip strength
Changes from baseline to 3-month and 9-month post-intervention
Balancing function
Changes from baseline to 3-month and 9-month post-intervention
Physical mobility level
Changes from baseline to 3-month and 9-month post-intervention
Sarcopenia risk
Changes from baseline to 3-month and 9-month post-intervention
Nutritional status
Changes from baseline to 3-month and 9-month post-intervention
- +6 more secondary outcomes
Study Arms (2)
Path-HA care
EXPERIMENTALA 14-week care initiative comprising two phases is provided, which are the 2-week ICOPE-based personalized care planning phase, and the 12-week healthy aging empowerment phase.
Control
NO INTERVENTIONNo care intervention will be provided.
Interventions
The ICOPE-based personalized care planning comprises two home visits. In 1st visit, a comprehensive assessment proposed by the WHO-ICOPE model is conducted to identify eight possible health problems including malnutrition, reduced physical fitness, fall risk, cognitive decline, insomnia, pain, psychological distress and social loneliness. After health problem identification, each participant receives a personalized care prescription. 2nd visit adopts a goal-oriented empowerment 3-step cycle to personalize the care planning: 1) communicating assessment results to increase healthy self-awareness; 2) supporting setting person-directed goals to address health problems; 3) identifying health actions and personalizing goal setting to participants' contexts. The 12-week healthy aging empowerment comprises three core activities for healthy aging promotion, including interactive health education, health message broadcasts, and three case conferences for goal monitoring and health counseling.
Eligibility Criteria
You may qualify if:
- \) aged 60 or above,
- \) with at least two risk factors of accelerating aging defined as including reduced physical functioning, malnutrition, depressed mood, loneliness, poor health perception, and presence of geriatric symptoms (e.g. insomnia, pain, etc), based on their health screening results,
- \) community-dwelling,
- \) communicable to engage in health education activity.
You may not qualify if:
- \) any who is not at or at only one risk factor of accelerating aging,
- \) any who has problems in communicating with the research team.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The University of Hong Kong
Hong Kong, Hong Kong
Study Officials
- PRINCIPAL INVESTIGATOR
Doris Sau Fung YU, PhD
The University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor (Chair, Research)
Study Record Dates
First Submitted
October 23, 2023
First Posted
October 30, 2023
Study Start
January 1, 2024
Primary Completion
June 30, 2025
Study Completion
March 31, 2026
Last Updated
December 16, 2025
Record last verified: 2025-12